DK0540591T3 - Cellenekrosepåvisning ved prøvning for spektrin og dets nedbrydningsprodukter - Google Patents

Cellenekrosepåvisning ved prøvning for spektrin og dets nedbrydningsprodukter

Info

Publication number
DK0540591T3
DK0540591T3 DK91913322.3T DK91913322T DK0540591T3 DK 0540591 T3 DK0540591 T3 DK 0540591T3 DK 91913322 T DK91913322 T DK 91913322T DK 0540591 T3 DK0540591 T3 DK 0540591T3
Authority
DK
Denmark
Prior art keywords
spectrin
bdp
sample
testing
separated
Prior art date
Application number
DK91913322.3T
Other languages
Danish (da)
English (en)
Inventor
Gary S Lynch
David D Eveleth Jr
Peter A Seubert
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0540591T3 publication Critical patent/DK0540591T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Electrochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK91913322.3T 1990-07-26 1991-07-11 Cellenekrosepåvisning ved prøvning for spektrin og dets nedbrydningsprodukter DK0540591T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/558,700 US5118606A (en) 1988-09-02 1990-07-26 Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products

Publications (1)

Publication Number Publication Date
DK0540591T3 true DK0540591T3 (da) 1996-02-05

Family

ID=24230602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913322.3T DK0540591T3 (da) 1990-07-26 1991-07-11 Cellenekrosepåvisning ved prøvning for spektrin og dets nedbrydningsprodukter

Country Status (10)

Country Link
US (1) US5118606A (fr)
EP (1) EP0540591B1 (fr)
JP (2) JP2824150B2 (fr)
AT (1) ATE128233T1 (fr)
CA (1) CA2088050A1 (fr)
DE (1) DE69113273T2 (fr)
DK (1) DK0540591T3 (fr)
ES (1) ES2077863T3 (fr)
GR (1) GR3017459T3 (fr)
WO (1) WO1992001935A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
US5536639A (en) * 1994-03-25 1996-07-16 Cephalon, Inc. Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
CA2188816C (fr) * 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition renfermant de l'o-fodrine ou un fragment proteinique d'o-fodrine
US6011991A (en) * 1998-12-07 2000-01-04 Technology Patents, Llc Communication system and method including brain wave analysis and/or use of brain activity
JP2005538380A (ja) * 2002-09-11 2005-12-15 ユニヴァーシティ オヴ フロリダ 神経細胞損傷の分析
JP4659025B2 (ja) 2004-04-15 2011-03-30 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 神経系傷害および他の神経障害についての生物マーカーとしての神経タンパク質
US8492107B2 (en) * 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
AU2005245785B2 (en) * 2004-04-15 2011-04-07 Banyan Biomarkers Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
WO2008097618A1 (fr) * 2007-02-06 2008-08-14 University Of Florida Research Foundation, Inc. Protéine médiatrice de réaction de synaptotagmine et collapsine en tant que biomarqueurs pour une lésion traumatique du cerveau
US8426565B2 (en) 2007-08-30 2013-04-23 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
WO2010019553A2 (fr) 2008-08-11 2010-02-18 Banyan Biomarkers, Inc. Procédé de détection de biomarqueurs et test d'état neurologique
EP2424560A4 (fr) * 2009-03-23 2013-11-27 Inst Medical W & E Hall Composés et procédés modulant une réponse immunitaire
EP2478355B1 (fr) * 2009-09-18 2018-11-14 The Regents of The University of California Procédés pour la détection d'autodigestion
CN103237558A (zh) 2010-10-02 2013-08-07 加利福尼亚大学董事会 最小化肠功能障碍
WO2012170669A1 (fr) * 2011-06-07 2012-12-13 Yale University Avenue Biomarqueurs pour évaluer la qualité moléculaire dans des spécimens biologiques
WO2019060298A1 (fr) 2017-09-19 2019-03-28 Neuroenhancement Lab, LLC Procédé et appareil de neuro-activation
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
WO2020056418A1 (fr) 2018-09-14 2020-03-19 Neuroenhancement Lab, LLC Système et procédé d'amélioration du sommeil
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US20230003741A1 (en) * 2019-11-26 2023-01-05 Ohio State Innovation Foundation Methods and compositions for cardiovascular disease detection and management

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432218B1 (fr) * 1988-09-02 1995-06-28 The Regents Of The University Of California Procede de detection de pathologie cellulaire

Also Published As

Publication number Publication date
JPH05508919A (ja) 1993-12-09
JP2824150B2 (ja) 1998-11-11
GR3017459T3 (en) 1995-12-31
EP0540591A1 (fr) 1993-05-12
US5118606A (en) 1992-06-02
JPH1130615A (ja) 1999-02-02
ES2077863T3 (es) 1995-12-01
CA2088050A1 (fr) 1992-01-27
ATE128233T1 (de) 1995-10-15
DE69113273T2 (de) 1996-05-15
WO1992001935A1 (fr) 1992-02-06
DE69113273D1 (de) 1995-10-26
EP0540591B1 (fr) 1995-09-20

Similar Documents

Publication Publication Date Title
DK0540591T3 (da) Cellenekrosepåvisning ved prøvning for spektrin og dets nedbrydningsprodukter
Van Raamsdonk et al. Detection of antigens and antibodies by an immuno-peroxidase method applied on thin longitudinal sections of SDS-polyacrylamide gels
DE69409401T2 (de) Schnelles immunologisches testverfahren zum nachweis von antikörpern oder antigenen einschliesslich gleichzeitiger nachweis probenextraktion und immunogener reaktion
WO1999042839A3 (fr) Traitement du cancer
IT8019675A0 (it) Procedimento per rivelare ligandi in campioni di prova e relativo reagente analitico.
BR7607029A (pt) Dispositivo para coleta de especimes liquidos assepticos e dispositivo e processo para recolher um especime asseptico de uma descarga de urina
Blancher et al. SDS-PAGE and western blotting techniques
ES2192611T3 (es) Procedimiento de eliminacion de la interferencia del factor reumatoide en los dosificados de diagnostico.
CA2178096A1 (fr) Substituts de cibles et batteries de reference ameliorees
ES2122231T3 (es) Inmunoanalisis para la deteccion de colageno tipo i o fragmentos de colageno correspondientes.
ES501734A0 (es) Un procedimiento para la deteccion de anticuerpos en una muestra de ensayo
NO161287C (no) Homogen immunologisk analysemetode, reagensmidler og proeveinnretning for bruk ved immunoanalysebestemmelse.
ES2145746T3 (es) Analisis de deteccion de hepatitis c.
ES2191316T3 (es) Procedimiento de deteccion de un material biologico diana, fase de captura, fase de deteccion y reactivo que las contiene.
NO974000L (no) Fremgangsmåte og forbindelser for påvisning av analytter, ved hjelp av remanensmålinger, samt anvendelse av slike forbindelser
DK33991A (da) Fremgangsmaade til paavisning af cellepatologi
ATA193888A (de) Verfahren zur quantitativen bestimmung des zustandes oder von zustandsaenderungen von inhomogenen proben
Nyhlin et al. Evaluation of immunohistochemical staining of human duodenal endocrine cells after microwave antigen retrieval
Allsup A comparison of the agar gel immuno-diffusion (AGID) and counter-immunoelectrophoresis (CIE) tests for species identification of imported red meat and offal
Abuknesha et al. Evaluation of a polyclonal antiserum to pentachlorothiophenol-acetic acid-KLH immunogen: binding properties and use with heterologous PCP derivatives in ELISA for pentachlorophenol
DK162726C (da) Fremgangsmaade til eliminering af falsk positive resultater ved bestemmelse af atl virus-antistof og reagens dertil
DK72082A (da) Cytoreceptor-proeve
ES504126A0 (es) Un metodo analitico para la determinacion de uno o mas para-metros en muestras de pruebas
KR20100018204A (ko) 바이오센서를 이용한 변압기 절연유 중 폴리염화비페닐류의분석방법
SU928191A1 (ru) Способ определени радиационной стойкости полимерных материалов